Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium.
Bone disease
Infection
Peripheral neuropathy
Renal insufficiency
Thrombosis
Journal
Clinical lymphoma, myeloma & leukemia
ISSN: 2152-2669
Titre abrégé: Clin Lymphoma Myeloma Leuk
Pays: United States
ID NLM: 101525386
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
26
01
2021
revised:
14
07
2021
accepted:
29
07
2021
pubmed:
31
8
2021
medline:
1
4
2022
entrez:
30
8
2021
Statut:
ppublish
Résumé
Multiple myeloma (MM) is a hematological cancer associated with significant symptomatic burden. Bone disease, renal insufficiency, cytopenias, infection, and peripheral neuropathy, among other disease manifestations and complications, impair patients' quality of life. The Canadian Myeloma Research Group Consensus Guideline Consortium, formerly Myeloma Canada Research Network Consensus Guideline Consortium, proposes national consensus recommendations for the management of MM-related manifestations and complications. To address the needs of Canadian physicians and people living with MM across the country, this document focuses on the improvement and maintenance of patient care by clarifying best-practice approaches for the prevention, detection and management of disease manifestations and complications. The Canadian Myeloma Research Group Consensus Guideline Consortium will periodically review the recommendations herein and update as necessary.
Identifiants
pubmed: 34456159
pii: S2152-2650(21)00311-6
doi: 10.1016/j.clml.2021.07.028
pii:
doi:
Types de publication
Guideline
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e41-e56Informations de copyright
Copyright © 2021. Published by Elsevier Inc.